Case report identifies metastatic clear cell renal cell carcinoma in a patient after nephrectomy, suggesting advanced diagnostic techniques are essential.
A 73‐year‐old man was referred for evaluation of mediastinal lymphadenopathy. He had undergone right nephrectomy for clear cell renal cell carcinoma (ccRCC; pT3aN0M0, stage III) 11 years earlier and had remained recurrence‐free without adjuvant therapy. Positron emission tomography/computed tomography (PET/CT) revealed an enlarged subcarinal lymph node which was non‐FDG avid. Bronchoscopy was performed to obtain a pathological diagnosis. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) initially yielded bloody and inadequate specimens on rapid on‐site cytologic evaluation (ROSE). The sampling technique was therefore switched to endobronchial ultrasound‐guided transbronchial needle capillary sampling (EBUS‐TBNCS), and ROSE demonstrated adequate cellular material with atypical cells. Histopathology and immunohistochemistry confirmed metastatic ccRCC. This case highlights that metastatic ccRCC should be considered in PET‐negative mediastinal lymphadenopathy more than a decade after nephrectomy and that EBUS‐TBNCS may facilitate diagnostic tissue acquisition when conventional EBUS‐TBNA yields bloody specimens.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: